Addressing Health Disparities: It Didn’t Begin with HIV and Won’t End with COVID-19
Release date: June 11, 2020
Expiration date: June 11, 2021
Estimated time to complete activity: 1 hour and 15 minutes
This activity is jointly provided by Annenberg Center for Health Sciences at Eisenhower and the American Academy of HIV Medicine, in collaboration with Postgraduate Institute for Medicine.
This activity is supported by independent education grants from Gilead Sciences, Janssen Therapeutics, Merck Pharmaceuticals and ViiV Healthcare.
Target Audience
This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, registered nurses and pharmacists.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the evolving epidemiology of HIV disease in the U.S., with an emphasis on age, gender, sexuality, race/ethnicity, socioeconomic status, emerging subtypes, and viral resistance or other topic specific subjects.
- Implement appropriate and current HIV testing methods and tailor ARV treatment to unique populations with HIV.
- Provide up-to-date HIV care to a broad spectrum of infected patient populations, including pediatrics, adolescents, injection-drug users, incarcerated individuals, and an aging population.
- Modify ART for HIV based upon the various co-morbitites that are often found in HIV-infected individuals including cardiovascular, renal, and neurologic disease.
- Discuss the ethical and legal issues related to caring for HIV-infected individuals.
Faculty:
Michelle Collins-Ogle, MD, FAAP, AAHIVS
Pediatric Infectious Diseases
Children’s Hospital at Montefiore
Assistant Professor Pediatrics
Einstein College of Medicine
Bronx, NY
Bronx, NY
Ada D. Stewart, RPh, MD, FAAFP, HMDC, AAHIVS
Lead Provider & HIV Specialist
Eau Claire Cooperative Health Centers
Columbia, SC
Eau Claire Cooperative Health Centers
Columbia, SC
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the American Academy of HIV Medicine. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Activity #0797-9999-20-049-H02-P. This program is designated for up to 1.25 contact hours (0.125 CEUs) of continuing pharmacy education credit.
Type of Activity: Knowledge
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Credit Designation
1.25 contact hours may be earned for successful completion of this activity.
Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Internet
Learners must have internet access to participate in the activity.
Fee Information: There is no fee for this educational activity.
Method of Participation and Request for Credit:
There are no fees for participating and receiving CME/CE credit for this activity. During the period June 11, 2020 through June 11, 2021 participants must read the learning objectives and faculty disclosures and study the educational activity.
If you wish to receive acknowledgment for completing this activity, please complete the evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 15375. Upon registering and completing the activity evaluation, your certificate will be made available immediately.
For Pharmacists: Please complete the evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 15375. Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Hardware and Software Requirements
CME University requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.